SCHEMBL16660376

SCHEMBL16660376

CC(CCC(=O)OC(C)(C)C)C(=O)OC(C)(C)C

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2D6 P10635 1/20 0.37
HDAC3 O15379 1/20 0.36
HDAC1 Q13547 1/20 0.36
HDAC2 Q92769 1/20 0.36
HDAC8 Q9BY41 1/20 0.36
HDAC6 Q9UBN7 1/20 0.36
NOS1 P29475 2/20 0.36
NOS3 P29474 1/20 0.36
NOS2 P35228 1/20 0.36
CYP1A2 P05177 1/20 0.34
CTSK P43235 1/20 0.33
CA1 P00915 1/20 0.33
CA2 P00918 1/20 0.33
CA7 P43166 1/20 0.33
APP P05067 1/20 0.33
PLA2G10 O15496 1/20 0.33
PLA2G5 P39877 1/20 0.33
MEN1 O00255 2/20 0.33
KMT2A Q03164 2/20 0.33
GAA P10253 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15984252 1.00 CYP2D6 (0.37) CYP2D6HDAC3HDAC1HDAC2HDAC8
SCHEMBL19691931 0.89 TSHR (0.43) CYP2D6NOS1NOS3NOS2CTSK
SCHEMBL13613730 0.89 TSHR (0.43) CYP2D6NOS1NOS3NOS2CTSK
SCHEMBL2616309 0.89 CA12 (0.39) CYP2D6HDAC3HDAC1HDAC2HDAC8
SCHEMBL22355214 0.87 LMNA (0.34) CYP2D6HDAC3HDAC1HDAC2HDAC8
SCHEMBL12171658 0.84 CYP1A2 (0.54) CYP2D6HDAC3HDAC1HDAC2HDAC8
SCHEMBL29307991 0.84 CYP2D6 (0.40) CYP2D6HDAC3HDAC1HDAC2HDAC8
SCHEMBL18134688 0.84 CYP1A2 (0.54) CYP2D6HDAC3HDAC1HDAC2HDAC8
SCHEMBL17227860 0.84 CYP1A2 (0.54) CYP2D6HDAC3HDAC1HDAC2HDAC8
SCHEMBL764174 0.84 CYP1A2 (0.54) CYP2D6NOS1NOS3NOS2CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150110715-A1 Double-Labeled Probe for Molecular Imaging and Use Thereof RUPRECHT-KARLS-UNIVERSITAT HEIDELBERG (DE) 2015-04-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150110715-A1 Double-Labeled Probe for Molecular Imaging and Use Thereof CD47, ANXA5, CD44 CYP2D6 4522/4885HDAC3 2620/4885HDAC1 3250/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.